×
Bringing together leading aging researchers and biotech investors for four action-packed days of science and business.
We are delighted to announce the fifth Ending Age-Related Diseases conference! On August 11-14, 2022, we will be meeting virtually to hear the latest developments from the leaders of rejuvenation biotechnology research and investment. We are announcing more speakers in the coming weeks and be sure to check out the full list of conference speakers.
George Church, Ph.D.
Harvard Medical School - Professor of Genetics
Irina Conboy, Ph.D.
UC Berkeley Research - Assistant Professor of Bioengineering
Brian Kennedy, Ph.D.
National University Singapore - Professor of Biochemistry and Physiology
Vadim Gladyshev, Ph.D.
Harvard Medical School
Steve Horvath, Ph.D.
David Geffen School of Medicine, UCLA
Greg Fahy, Ph.D.
Intervene Immune - CSO
Kris Verburgh, M.D.
NOVOS - Co-founder
Hanadie Yousef, Ph.D.
Juvena Therapeutics
Matthew O'Connor, Ph.D.
Underdog Pharmaceuticals
Alexandra Stolzing, Ph.D.
SENS Research Foundation - Vice President of Research
João Pedro de Magalhães, Ph.D.
University of Liverpool
Marco Quarta, Ph.D.
Rubedo Life Sciences - CEO
This conference will bring together the leading experts in rejuvenation biotechnology and investment in order to foster scientific and business collaborations to develop rejuvenation therapies that target the root causes of aging.
Conference Program
Join us for four days filled with insightful talks about how we can develop rejuvenation therapies for healthy life extension and end age-related diseases more quickly! An initial program will be published soon.
We are offering a range of appealing sponsorship packages. Please contact Steve to discuss your sponsorship package.
If you would like to stay informed about speakers, special offers on tickets and more, then register and tick the newsletter box.
The Conference for Rejuvenation Biotechnology and Life Extension
Official Sponsors
Platinum
